tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

REGN Stock Latest News

Early notable gainers among liquid option names on November 20th
The FlyEarly notable gainers among liquid option names on November 20th
2d ago
APP
CEG
Video: Nvidia results ease AI bubble concerns, boost market
PremiumThe Fly
Video: Nvidia results ease AI bubble concerns, boost market
2d ago
WMT
BBWI
Regeneron’s Promising Outlook: Overcoming Regulatory Hurdles and Expanding Eylea HD’s Market Potential
PremiumRatings
Regeneron’s Promising Outlook: Overcoming Regulatory Hurdles and Expanding Eylea HD’s Market Potential
2d ago
REGN
Positive Outlook for Regeneron: Buy Rating Supported by Eylea HD Approval and Strong Portfolio
PremiumRatings
Positive Outlook for Regeneron: Buy Rating Supported by Eylea HD Approval and Strong Portfolio
2d ago
REGN
Regeneron: Positive Developments and Strategic Investments Support Buy Rating and $850 Price Target
PremiumRatings
Regeneron: Positive Developments and Strategic Investments Support Buy Rating and $850 Price Target
2d ago
REGN
Regeneron price target raised to $700 from $615 at Wells Fargo
PremiumThe FlyRegeneron price target raised to $700 from $615 at Wells Fargo
2d ago
REGN
Regeneron: Strategic Positioning and Growth Potential with Eylea-HD Approval
Premium
Ratings
Regeneron: Strategic Positioning and Growth Potential with Eylea-HD Approval
2d ago
REGN
Regeneron trading resumes
Premium
The Fly
Regeneron trading resumes
3d ago
REGN
Regeneron announces FDA approval for Eylea HD Injection 8 mg for macular edema
PremiumThe Fly
Regeneron announces FDA approval for Eylea HD Injection 8 mg for macular edema
3d ago
REGN
Regeneron trading halted, news pending
PremiumThe Fly
Regeneron trading halted, news pending
3d ago
REGN
Regeneron announces EC approved Libtayo for adults with CSCC
PremiumThe Fly
Regeneron announces EC approved Libtayo for adults with CSCC
3d ago
REGN
REGN, GMAB, ARWR: Which Healthcare Stock Is Best Buy Ahead of U.S. Drug Approvals This Nov?
PremiumMarket News
REGN, GMAB, ARWR: Which Healthcare Stock Is Best Buy Ahead of U.S. Drug Approvals This Nov?
8d ago
NVS
ARWR
Cathie Wood Sells AMD Stock, Pours Millions into These 2 Crypto Plays
PremiumMarket NewsCathie Wood Sells AMD Stock, Pours Millions into These 2 Crypto Plays
8d ago
AMD
CRM
Nike upgraded, Dollar Tree downgraded: Wall Street’s top analyst calls
Premium
The Fly
Nike upgraded, Dollar Tree downgraded: Wall Street’s top analyst calls
9d ago
AZO
BMY
Scotiabank starts 10 large cap drugmakers with ‘out-of-consensus’ positive view
Premium
The Fly
Scotiabank starts 10 large cap drugmakers with ‘out-of-consensus’ positive view
9d ago
BMY
JNJ
Regeneron announces new, updated data from hematology pipeline
PremiumThe Fly
Regeneron announces new, updated data from hematology pipeline
9d ago
REGN
Regeneron initiated with a Sector Perform at Scotiabank
PremiumThe Fly
Regeneron initiated with a Sector Perform at Scotiabank
10d ago
REGN
Regeneron: Strong Buy Rating Backed by Robust Business and Promising Oncology Developments
PremiumRatings
Regeneron: Strong Buy Rating Backed by Robust Business and Promising Oncology Developments
11d ago
REGN
Regeneron’s Innovative Anticoagulation Advancements and Market Potential Drive Buy Rating
PremiumRatings
Regeneron’s Innovative Anticoagulation Advancements and Market Potential Drive Buy Rating
11d ago
REGN
Regeneron treatment of pulmonary arterial hypertension granted orphan status
PremiumThe FlyRegeneron treatment of pulmonary arterial hypertension granted orphan status
12d ago
REGN
Sanofi, Regeneron report all primary endpoints met in LIBERTY-AFRS-AIMS study
Premium
The Fly
Sanofi, Regeneron report all primary endpoints met in LIBERTY-AFRS-AIMS study
15d ago
SNY
REGN
Regeneron, Sanofi announces presentation of Phase 3 trial of Dupixent
Premium
The Fly
Regeneron, Sanofi announces presentation of Phase 3 trial of Dupixent
15d ago
SNY
REGN

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >